LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 259

Search options

  1. Article ; Online: Iron Responsiveness to Lysosomal Disruption: A Novel Pathway to Alzheimer's Disease.

    Rogers, Jack T / Cahill, Catherine M

    Journal of Alzheimer's disease : JAD

    2023  Volume 96, Issue 1, Page(s) 41–45

    Abstract: Familial Alzheimer's disease (fAD) mutations in the amyloid-β protein precursor (AβPP) enhance brain AβPP C-Terminal Fragment (CTF) levels to inhibit lysosomal v-ATPase. Consequent disrupted acidification of the endolysosomal pathway may trigger brain ... ...

    Abstract Familial Alzheimer's disease (fAD) mutations in the amyloid-β protein precursor (AβPP) enhance brain AβPP C-Terminal Fragment (CTF) levels to inhibit lysosomal v-ATPase. Consequent disrupted acidification of the endolysosomal pathway may trigger brain iron deficiencies and mitochondrial dysfunction. The iron responsive element (IRE) in the 5'Untranslated-region of AβPP mRNA should be factored into this cycle where reduced bioavailable Fe-II would decrease IRE-dependent AβPP translation and levels of APP-CTFβ in a cycle to adaptively restore iron homeostasis while increases of transferrin-receptors is evident. In healthy younger individuals, Fe-dependent translational modulation of AβPP is part of the neuroprotective function of sAβPPα with its role in iron transport.
    MeSH term(s) Humans ; Alzheimer Disease/genetics ; Alzheimer Disease/metabolism ; Iron/metabolism ; Protein Biosynthesis ; Amyloid beta-Protein Precursor/genetics ; Amyloid beta-Protein Precursor/metabolism ; Lysosomes/metabolism ; Amyloid beta-Peptides/metabolism
    Chemical Substances Iron (E1UOL152H7) ; Amyloid beta-Protein Precursor ; Amyloid beta-Peptides
    Language English
    Publishing date 2023-10-12
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1440127-7
    ISSN 1875-8908 ; 1387-2877
    ISSN (online) 1875-8908
    ISSN 1387-2877
    DOI 10.3233/JAD-230953
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Opioid dose regimen shapes mesolimbic adaptations.

    Cahill, Catherine M

    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

    2020  Volume 45, Issue 11, Page(s) 1777–1778

    MeSH term(s) Analgesics, Opioid ; Narcotic Antagonists ; Receptors, Opioid, mu
    Chemical Substances Analgesics, Opioid ; Narcotic Antagonists ; Receptors, Opioid, mu
    Keywords covid19
    Language English
    Publishing date 2020-04-29
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, P.H.S.
    ZDB-ID 639471-1
    ISSN 1740-634X ; 0893-133X
    ISSN (online) 1740-634X
    ISSN 0893-133X
    DOI 10.1038/s41386-020-0679-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Unveiling the link between chronic pain and misuse of opioids and cannabis.

    Dagher, Merel / Alayoubi, Myra / Sigal, Gabriella H / Cahill, Catherine M

    Journal of neural transmission (Vienna, Austria : 1996)

    2024  Volume 131, Issue 5, Page(s) 563–580

    Abstract: Over 50 million Americans endure chronic pain where many do not receive adequate treatment and self-medicate to manage their pain by taking substances like opioids and cannabis. Research has shown high comorbidity between chronic pain and substance use ... ...

    Abstract Over 50 million Americans endure chronic pain where many do not receive adequate treatment and self-medicate to manage their pain by taking substances like opioids and cannabis. Research has shown high comorbidity between chronic pain and substance use disorders (SUD) and these disorders share many common neurobiological underpinnings, including hypodopaminergic transmission. Drugs commonly used for self-medication such as opioids and cannabis relieve emotional, bothersome components of pain as well as negative emotional affect that perpetuates misuse and increases the risk of progressing towards drug abuse. However, the causal effect between chronic pain and the development of SUDs has not been clearly established. In this review, we discuss evidence that affirms the proposition that chronic pain is a risk factor for the development of opioid and cannabis use disorders by outlining the clinical evidence and detailing neurobiological mechanisms that link pain and drug misuse. Central to the link between chronic pain and opioid and cannabis misuse is hypodopaminergic transmission and the modulation of dopamine signaling in the mesolimbic pathway by opioids and cannabis. Moreover, we discuss the role of kappa opioid receptor activation and neuroinflammation in the context of dopamine transmission, their contribution to opioid and cannabis withdrawal, along with potential new treatments.
    MeSH term(s) Humans ; Chronic Pain/drug therapy ; Chronic Pain/physiopathology ; Analgesics, Opioid/adverse effects ; Opioid-Related Disorders ; Animals ; Marijuana Abuse/complications ; Marijuana Abuse/physiopathology
    Chemical Substances Analgesics, Opioid
    Language English
    Publishing date 2024-04-03
    Publishing country Austria
    Document type Journal Article ; Review ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 184163-4
    ISSN 1435-1463 ; 0300-9564
    ISSN (online) 1435-1463
    ISSN 0300-9564
    DOI 10.1007/s00702-024-02765-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Editorial: Broadening our conceptual understanding of endogenous opioids in systems neuroscience.

    Tejeda, Hugo A / Massaly, Nicolas / Corder, Gregory / Cahill, Catherine M

    Frontiers in systems neuroscience

    2023  Volume 17, Page(s) 1212650

    Language English
    Publishing date 2023-06-13
    Publishing country Switzerland
    Document type Editorial
    ZDB-ID 2453005-0
    ISSN 1662-5137
    ISSN 1662-5137
    DOI 10.3389/fnsys.2023.1212650
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Opioid Systems and Depression: The Relationship Is Strengthening.

    Dagher, Merel / Cahill, Catherine M / Evans, Christopher J

    Biological psychiatry

    2022  Volume 92, Issue 12, Page(s) 920–922

    MeSH term(s) Humans ; Analgesics, Opioid/adverse effects ; Depression ; Opioid-Related Disorders
    Chemical Substances Analgesics, Opioid
    Language English
    Publishing date 2022-11-14
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 209434-4
    ISSN 1873-2402 ; 0006-3223
    ISSN (online) 1873-2402
    ISSN 0006-3223
    DOI 10.1016/j.biopsych.2022.09.020
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Iron-responsive-like elements and neurodegenerative ferroptosis.

    Rogers, Jack T / Cahill, Catherine M

    Learning & memory (Cold Spring Harbor, N.Y.)

    2020  Volume 27, Issue 9, Page(s) 395–413

    Abstract: A set of common-acting iron-responsive 5'untranslated region (5'UTR) motifs can fold into RNA stem loops that appear significant to the biology of cognitive declines of Parkinson's disease dementia (PDD), Lewy body dementia (LDD), and Alzheimer's disease ...

    Abstract A set of common-acting iron-responsive 5'untranslated region (5'UTR) motifs can fold into RNA stem loops that appear significant to the biology of cognitive declines of Parkinson's disease dementia (PDD), Lewy body dementia (LDD), and Alzheimer's disease (AD). Neurodegenerative diseases exhibit perturbations of iron homeostasis in defined brain subregions over characteristic time intervals of progression. While misfolding of Aβ from the amyloid-precursor-protein (APP), alpha-synuclein, prion protein (PrP) each cause neuropathic protein inclusions in the brain subregions, iron-responsive-like element (IRE-like) RNA stem-loops reside in their transcripts. APP and αsyn have a role in iron transport while gene duplications elevate the expression of their products to cause rare familial cases of AD and PDD. Of note, IRE-like sequences are responsive to excesses of brain iron in a potential feedback loop to accelerate neuronal ferroptosis and cognitive declines as well as amyloidosis. This pathogenic feedback is consistent with the translational control of the iron storage protein ferritin. We discuss how the IRE-like RNA motifs in the 5'UTRs of APP, alpha-synuclein and PrP mRNAs represent uniquely folded drug targets for therapies to prevent perturbed iron homeostasis that accelerates AD, PD, PD dementia (PDD) and Lewy body dementia, thus preventing cognitive deficits. Inhibition of alpha-synuclein translation is an option to block manganese toxicity associated with early childhood cognitive problems and manganism while Pb toxicity is epigenetically associated with attention deficit and later-stage AD. Pathologies of heavy metal toxicity centered on an embargo of iron export may be treated with activators of APP and ferritin and inhibitors of alpha-synuclein translation.
    MeSH term(s) 5' Untranslated Regions/drug effects ; Amyloid beta-Peptides/drug effects ; Amyloid beta-Peptides/metabolism ; Animals ; Ferritins/drug effects ; Ferritins/metabolism ; Ferroptosis/drug effects ; Ferroptosis/physiology ; Heavy Metal Poisoning/drug therapy ; Heavy Metal Poisoning/metabolism ; Heavy Metal Poisoning/physiopathology ; Humans ; Iron-Regulatory Proteins/drug effects ; Iron-Regulatory Proteins/metabolism ; Neurocognitive Disorders/drug therapy ; Neurocognitive Disorders/metabolism ; Neurodegenerative Diseases/drug therapy ; Neurodegenerative Diseases/metabolism ; Neuroprotective Agents/pharmacology ; Protein Biosynthesis/drug effects ; alpha-Synuclein/drug effects ; alpha-Synuclein/metabolism
    Chemical Substances 5' Untranslated Regions ; Amyloid beta-Peptides ; Iron-Regulatory Proteins ; Neuroprotective Agents ; alpha-Synuclein ; Ferritins (9007-73-2)
    Language English
    Publishing date 2020-08-17
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 1204777-6
    ISSN 1549-5485 ; 1072-0502
    ISSN (online) 1549-5485
    ISSN 1072-0502
    DOI 10.1101/lm.052282.120
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Evidence and Function Relevance of Native DOR-MOR Heteromers.

    Cahill, Catherine M / Ong, Edmund

    Handbook of experimental pharmacology

    2018  Volume 247, Page(s) 115–127

    Abstract: ... heteromers. Owing to their constituent monomers' involvement in analgesia, mu/delta opioid receptor (M/DOR ... indisputable proof of M/DOR formation in vivo are still evolving. This aspect of the field has been slow ...

    Abstract Opioid receptors are the sites of action for morphine and most other clinically used opioid drugs. Abundant evidence now demonstrates that different opioid receptor types can physically associate to form heteromers. Owing to their constituent monomers' involvement in analgesia, mu/delta opioid receptor (M/DOR) heteromers have been a particular focus of attention. Understandings of the physiological relevance and indisputable proof of M/DOR formation in vivo are still evolving. This aspect of the field has been slow to progress in large part by the limitations of most available experimental models; recently however, promising progress is being made. As a result, the long-repeated promise of opioid receptor heteromers as selective therapeutic targets is now being realized.
    MeSH term(s) Analgesics, Opioid/pharmacology ; Animals ; Drug Design ; Humans ; Ligands ; Protein Multimerization ; Receptors, Opioid, delta/drug effects ; Receptors, Opioid, delta/physiology ; Receptors, Opioid, mu/drug effects ; Receptors, Opioid, mu/physiology
    Chemical Substances Analgesics, Opioid ; Ligands ; OPRM1 protein, human ; Receptors, Opioid, delta ; Receptors, Opioid, mu
    Language English
    Publishing date 2018-03-26
    Publishing country Germany
    Document type Journal Article ; Review
    ISSN 0171-2004
    ISSN 0171-2004
    DOI 10.1007/164_2018_112
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Fentanyl: Receptor pharmacology, abuse potential, and implications for treatment.

    Comer, Sandra D / Cahill, Catherine M

    Neuroscience and biobehavioral reviews

    2018  Volume 106, Page(s) 49–57

    Abstract: Opioid overdoses, many of which are attributed to use of illicit fentanyl, are currently one of the leading causes of death in the U.S. Although fentanyl has been used safely for decades in clinical settings, the widespread use of illicit fentanyl is a ... ...

    Abstract Opioid overdoses, many of which are attributed to use of illicit fentanyl, are currently one of the leading causes of death in the U.S. Although fentanyl has been used safely for decades in clinical settings, the widespread use of illicit fentanyl is a recent phenomenon. Starting in 2013, illicitly manufactured fentanyl and its analogs began to appear on the streets. These substances were added to or sold as heroin, often unbeknownst to the user. Because fentanyl is so potent, only small amounts are needed to produce pharmacological effects, but the margin between safe and toxic doses is narrow. Surprisingly little is known about the exact signaling mechanisms underlying fentanyl-related respiratory depression or the effectiveness of naloxone in reversing this effect. Similarly, little is known about the ability of treatment medications such as buprenorphine, methadone, or naltrexone to reduce illicit fentanyl use. The present article reviews the receptor, preclinical and clinical pharmacology of fentanyl, and how its pharmacology may predict the effectiveness of currently approved medications for treating illicit fentanyl use.
    MeSH term(s) Analgesics, Opioid/pharmacology ; Fentanyl/pharmacology ; Humans ; Opiate Substitution Treatment/methods ; Opioid-Related Disorders/drug therapy ; Opioid-Related Disorders/epidemiology ; Receptors, Opioid, mu/agonists
    Chemical Substances Analgesics, Opioid ; Receptors, Opioid, mu ; Fentanyl (UF599785JZ)
    Language English
    Publishing date 2018-12-05
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S. ; Review
    ZDB-ID 282464-4
    ISSN 1873-7528 ; 0149-7634
    ISSN (online) 1873-7528
    ISSN 0149-7634
    DOI 10.1016/j.neubiorev.2018.12.005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Pain Catastrophizing Is Associated With Increased Alcohol Cue-Elicited Neural Activity Among Individuals With Alcohol Use Disorder.

    Nieto, Steven J / Grodin, Erica N / Burnette, Elizabeth M / Cahill, Catherine M / Ray, Lara A

    Alcohol and alcoholism (Oxford, Oxfordshire)

    2022  Volume 57, Issue 6, Page(s) 727–733

    Abstract: Aims: The current study examined the association between pain catastrophizing and alcohol cue-elicited brain activation in individuals with alcohol use disorder (AUD).: Methods: Non-treatment seeking heavy drinkers with AUD (n = 45; 28 males) ... ...

    Abstract Aims: The current study examined the association between pain catastrophizing and alcohol cue-elicited brain activation in individuals with alcohol use disorder (AUD).
    Methods: Non-treatment seeking heavy drinkers with AUD (n = 45; 28 males) completed self-report measures of pain catastrophizing and alcohol use/problems as part of a clinical trial of the neuroimmune modulator ibudilast. Participants were randomized to either placebo (n = 25) or ibudilast (n = 20) and completed an functional magnetic resonance imaging (fMRI) scan to assess neural activation to alcohol cues 1 week into the medication trial. Multiple linear regression examined whether pain catastrophizing predicted cue-induced activation in a priori regions of interest, namely the dorsal and ventral striatum (VS). An exploratory whole-brain analysis was conducted to assess the relationship between pain catastrophizing and neural alcohol cue reactivity.
    Results: Pain catastrophizing predicted greater cue-induced activation in the dorsal (b = 0.006; P = 0.03) but not VS controlling for medication. Pain catastrophizing was positively associated with neural activation to alcohol cues in regions including the bilateral thalamus, left precuneus and left frontal pole.
    Conclusion: Greater pain catastrophizing is associated with greater cue-induced neural activation in brain regions sub-serving habits and compulsive alcohol use. These findings provide initial support for a neural mechanism by which pain catastrophizing may drive alcohol craving among individuals with AUD.
    MeSH term(s) Male ; Humans ; Alcoholism/drug therapy ; Cues ; Catastrophization ; Alcohol Drinking ; Craving/physiology ; Magnetic Resonance Imaging/methods ; Brain/physiology ; Ethanol
    Chemical Substances Ethanol (3K9958V90M)
    Language English
    Publishing date 2022-06-30
    Publishing country England
    Document type Randomized Controlled Trial ; Journal Article
    ZDB-ID 604956-4
    ISSN 1464-3502 ; 0309-1635 ; 0735-0414
    ISSN (online) 1464-3502
    ISSN 0309-1635 ; 0735-0414
    DOI 10.1093/alcalc/agac029
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Neuroinflammation drives sex-dependent effects on pain and negative affect in a murine model of repeated mild traumatic brain injury.

    Liu, Shiwei Steve / Pickens, Sarah / Barta, Zack / Rice, Myra / Dagher, Merel / Lebens, Ryan / Nguyen, Theodore V / Cummings, Brian J / Cahill, Catherine M

    Pain

    2023  Volume 165, Issue 4, Page(s) 848–865

    Abstract: Abstract: The Center for Disease Control and Prevention estimates that 75% of reported cases of traumatic brain injury (TBI) are mild, where chronic pain and depression are 2 of the most common symptoms. In this study, we used a murine model of repeated ...

    Abstract Abstract: The Center for Disease Control and Prevention estimates that 75% of reported cases of traumatic brain injury (TBI) are mild, where chronic pain and depression are 2 of the most common symptoms. In this study, we used a murine model of repeated mild TBI to characterize the associated pain hypersensitivity and affective-like behavior and to what extent microglial reactivity contributes to these behavioral phenotypes. Male and female C57BL/6J mice underwent sham or repeated mild traumatic brain injury (rmTBI) and were tested for up to 9 weeks postinjury, where an anti-inflammatory/neuroprotective drug (minocycline) was introduced at 5 weeks postinjury in the drinking water. Repeated mild traumatic brain injury mice developed cold nociceptive hypersensitivity and negative affective states, as well as increased locomotor activity and risk-taking behavior. Minocycline reversed negative affect and pain hypersensitivities in male but not female mice. Repeated mild traumatic brain injury also produced an increase in microglial and brain-derived neurotropic factor mRNA transcripts in limbic structures known to be involved in nociception and affect, but many of these changes were sex dependent. Finally, we show that the antiepileptic drug, gabapentin, produced negative reinforcement in male rmTBI mice that was prevented by minocycline treatment, whereas rmTBI female mice showed a place aversion to gabapentin. Collectively, pain hypersensitivity, increased tonic-aversive pain components, and negative affective states were evident in both male and female rmTBI mice, but suppression of microglial reactivity was only sufficient to reverse behavioral changes in male mice. Neuroinflammation in limbic structures seems to be a contributing factor in behavioral changes resulting from rmTBI.
    MeSH term(s) Mice ; Male ; Female ; Animals ; Brain Concussion/complications ; Brain Concussion/psychology ; Neuroinflammatory Diseases ; Disease Models, Animal ; Minocycline/pharmacology ; Minocycline/therapeutic use ; Gabapentin ; Mice, Inbred C57BL ; Pain
    Chemical Substances Minocycline (FYY3R43WGO) ; Gabapentin (6CW7F3G59X)
    Language English
    Publishing date 2023-11-08
    Publishing country United States
    Document type Journal Article
    ZDB-ID 193153-2
    ISSN 1872-6623 ; 0304-3959
    ISSN (online) 1872-6623
    ISSN 0304-3959
    DOI 10.1097/j.pain.0000000000003084
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top